SMARCD1 and type 2 diabetes mellitus: Western blotting and immunofluorescence confirmed a marked reduction of BAF60a protein in islets from diabetic mice (Figure 1, J–M), obese/diabetic monkeys (Figure 1, N and O), and patients with T2D (Figure 1, P and Q, and Supplemental Figure 1G).